Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Caredx Inc (CDNA)

Caredx Inc (CDNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 862,278
  • Shares Outstanding, K 53,458
  • Annual Sales, $ 296,400 K
  • Annual Income, $ -30,660 K
  • 60-Month Beta 1.02
  • Price/Sales 2.90
  • Price/Cash Flow N/A
  • Price/Book 1.93
Trade CDNA with:

Options Overview Details

View History
  • Implied Volatility 118.11% ( -11.45%)
  • Historical Volatility 62.61%
  • IV Percentile 98%
  • IV Rank 85.85%
  • IV High 129.56% on 09/22/22
  • IV Low 48.63% on 11/16/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 11
  • Volume Avg (30-Day) 27
  • Put/Call OI Ratio 0.49
  • Today's Open Interest 951
  • Open Int (30-Day) 1,113

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.41
  • Number of Estimates 2
  • High Estimate -0.40
  • Low Estimate -0.42
  • Prior Year -0.23
  • Growth Rate Est. (year over year) -78.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.66 +3.00%
on 09/23/22
22.03 -26.78%
on 08/26/22
-4.71 (-22.60%)
since 08/23/22
3-Month
15.66 +3.00%
on 09/23/22
27.33 -40.98%
on 08/08/22
-7.90 (-32.88%)
since 06/23/22
52-Week
15.66 +3.00%
on 09/23/22
75.92 -78.75%
on 10/19/21
-50.64 (-75.84%)
since 09/23/21

Most Recent Stories

More News
CareDx Showcases Transplant Digital Leadership in Patient Care at 2022 MEET Conference

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients...

CDNA : 16.13 (+0.44%)
CareDx Celebrates 1 Million Organ Transplants and 100,000 Patient Milestone

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients...

CDNA : 16.13 (+0.44%)
Icon PLC (ICLR) Surges 3%: Is This an Indication of Further Gains?

Icon PLC (ICLR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road....

ICLR : 190.84 (-0.09%)
CDNA : 16.13 (+0.44%)
CareDx Demonstrates Global Leadership at 29th International Congress of The Transplantation Society

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients...

CDNA : 16.13 (+0.44%)
Cathie Wood Goes Bargain-Shopping: 3 Stocks She Just Bought

All three of these businesses dominate the relatively new niches they operate in.

EXAS : 33.41 (-2.74%)
CDNA : 16.13 (+0.44%)
BFLY : 4.80 (-3.81%)
CareDx and MOTTEP Co-Host Health Equity Summit

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients...

CDNA : 16.13 (+0.44%)
CareDx (CDNA) Reports Q2 Loss, Lags Revenue Estimates

CareDx (CDNA) delivered earnings and revenue surprises of -62.50% and 3.05%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

CDNA : 16.13 (+0.44%)
IDXG : 1.9000 (-2.06%)
CareDx Reports Second Quarter 2022 Results

CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients...

CDNA : 16.13 (+0.44%)
CareDx Unveils New Patient-Centered Medication Management Features on AlloCare Mobile Health App

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients...

CDNA : 16.13 (+0.44%)
CareDx Launches Personalized AlloHome Patient Monitoring Solution to Augment Pre- and Post-Transplant Care

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients...

CDNA : 16.13 (+0.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of...

See More

Key Turning Points

3rd Resistance Point 16.87
2nd Resistance Point 16.54
1st Resistance Point 16.33
Last Price 16.13
1st Support Level 15.79
2nd Support Level 15.46
3rd Support Level 15.25

See More

52-Week High 75.92
Fibonacci 61.8% 52.90
Fibonacci 50% 45.79
Fibonacci 38.2% 38.68
Last Price 16.13
52-Week Low 15.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar